Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 4
1948 2
1949 5
1950 3
1952 3
1953 7
1954 2
1955 2
1956 5
1957 3
1958 4
1959 4
1960 3
1961 3
1962 5
1963 3
1964 4
1965 5
1966 5
1967 5
1968 2
1969 3
1970 3
1971 1
1972 4
1973 2
1976 1
1977 1
1978 1
1979 2
1981 1
1982 1
1984 1
1985 2
1986 1
1987 5
1988 6
1989 4
1990 7
1991 7
1992 11
1993 6
1994 6
1995 6
1996 5
1997 9
1998 7
1999 6
2000 2
2001 2
2002 6
2003 13
2004 6
2005 7
2006 10
2007 7
2008 6
2009 7
2010 9
2011 6
2012 11
2013 7
2014 8
2015 5
2016 6
2017 5
2018 6
2019 6
2020 6
2021 13
2022 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

334 results

Results by year

Filters applied: . Clear all
Page 1
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism.
Pristipino C, Sievert H, D'Ascenzo F, Louis Mas J, Meier B, Scacciatella P, Hildick-Smith D, Gaita F, Toni D, Kyrle P, Thomson J, Derumeaux G, Onorato E, Sibbing D, Germonpré P, Berti S, Chessa M, Bedogni F, Dudek D, Hornung M, Zamorano J; Evidence Synthesis Team; Eapci Scientific Documents and Initiatives Committee; International Experts. Pristipino C, et al. Among authors: kyrle p. Eur Heart J. 2019 Oct 7;40(38):3182-3195. doi: 10.1093/eurheartj/ehy649. Eur Heart J. 2019. PMID: 30358849 Free article. Review.
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Greinacher A, et al. Among authors: kyrle pa. N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9. N Engl J Med. 2021. PMID: 33835769 Free PMC article.
Oral rivaroxaban for symptomatic venous thromboembolism.
EINSTEIN Investigators; Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. EINSTEIN Investigators, et al. N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3. N Engl J Med. 2010. PMID: 21128814 Free article. Clinical Trial.
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators. Weitz JI, et al. N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18. N Engl J Med. 2017. PMID: 28316279 Free article. Clinical Trial.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
Hereditary angioedema: beyond swelling.
Kyrle PA, Eichinger S. Kyrle PA, et al. Blood. 2024 Jul 25;144(4):354-355. doi: 10.1182/blood.2024024958. Blood. 2024. PMID: 39052271 No abstract available.
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.
Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA; Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Kearon C, et al. Among authors: kyrle pa. J Thromb Haemost. 2016 Jul;14(7):1480-3. doi: 10.1111/jth.13336. Epub 2016 Jun 7. J Thromb Haemost. 2016. PMID: 27428935 Free article. No abstract available.
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F, Rahman A, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Eichinger S, Kyrle PA, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Prins MH, Sabri E, Hutton B, Pinede L, Cushman M, Palareti G, Wells GA, Prandoni P, Büller HR, Rodger MA; MARVELOUS Collaborators. Khan F, et al. Among authors: kyrle pa. BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363. BMJ. 2019. PMID: 31340984 Free PMC article.
Deep vein thrombosis.
Kyrle PA, Eichinger S. Kyrle PA, et al. Lancet. 2005 Mar 26-Apr 1;365(9465):1163-74. doi: 10.1016/S0140-6736(05)71880-8. Lancet. 2005. PMID: 15794972 Review.
The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders.
Eichinger S, Morange PE, Cattaneo M, Fretigny M, Rauch A, van Hylckama Vlieg A, Trégouët DA, Ruf W, Levi M, Páramo JA, van der Poll T, Kyrle PA, Garagiola I, Peyvandi F. Eichinger S, et al. Among authors: kyrle pa. Hemasphere. 2021 Sep 10;5(10):e643. doi: 10.1097/HS9.0000000000000643. eCollection 2021 Oct. Hemasphere. 2021. PMID: 34522845 Free PMC article.
334 results